A comparable β cell mass and a trend toward increase in insulin levels between the female mTOR-KOPlacenta and controls suggested insufficient compensation to combat insulin resistance present in the mTOR-KOPlacenta offspring. The gene discussed is INS; the disease is Insulin resistance.